Last reviewed · How we verify
Placebo of Quick-Acting Heart Reliever
A placebo formulation with no active pharmaceutical ingredient, used as a control or comparative reference in clinical settings.
A placebo formulation with no active pharmaceutical ingredient, used as a control or comparative reference in clinical settings. Used for Acute heart symptoms (as a control/reference product in clinical research).
At a glance
| Generic name | Placebo of Quick-Acting Heart Reliever |
|---|---|
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
Mechanism of action
This is a placebo product, meaning it contains no active drug substance and produces therapeutic effects primarily through the placebo effect—the patient's expectation and belief in treatment. It is typically used in clinical trials or research contexts as a control arm to measure the efficacy of active treatments against baseline or psychological response.
Approved indications
- Acute heart symptoms (as a control/reference product in clinical research)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: